Mylab Discovery Solutions in Pune has launched the ‘Compact XL’ system for conducting a wide range of tests, including RT-PCR tests for covid-19. The system can test 32 tests at a time on one system and there are options to connect multiple systems on one network, the company said in a press conference.
Daily Current Affairs Quiz 2020
Key-Points
MyLab was one of the earliest entrants in domestic manufacturing of RT-PCR diagnostic kits for covid-19.
After getting approval for its product from the Indian Council of Medical Research and Drug Controller General of India ramp up production of Covid-19 testing kits and to expand its molecular diagnostic solutions.
The government’s insistence of conducting covid-19 tests only following a doctor’s prescription has been the biggest bottleneck for the company.
Mylab is currently operating at less than half of its capacity of 2 million per week due to low demand in the country and the prohibition of exports by the government.
So far, around 10 million tests have been conducted for covid-19 in India, for which about 20% of the kits were supplied by MyLab.
Poonawalla also concurred saying that the government’s insistence on doctor’s prescription is keeping asymptomatic patients out of the radar, which is leading to undertesting of the disease in the country.
